This inventor holds 8 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Opus Genetics, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Alan R Meyer: Innovator in Ophthalmic Solutions
Introduction
Alan R Meyer is a notable inventor based in North Riverside, IL (US). He has made significant contributions to the field of ophthalmology, particularly through his innovative patents. With a total of 8 patents, Meyer has focused on developing solutions that enhance visual performance and address various ocular disorders.
Latest Patents
Meyer’s latest patents include "Aqueous ophthalmic solutions of phentolamine and medical uses thereof." This invention provides aqueous ophthalmic solutions of phentolamine or pharmaceutically acceptable salts, along with medical kits and methods for using these solutions to improve visual performance in patients. The exemplary solutions contain phentolamine mesylate, mannitol, sodium acetate, and water. Another significant patent is "Methods and compositions for treatment of mydriasis." This invention outlines methods, compositions, and kits that include an alpha-adrenergic antagonist, such as phentolamine, for treating patients suffering from presbyopia, mydriasis, and other ocular disorders.
Career Highlights
Alan R Meyer is currently associated with Opus Genetics, Inc., where he continues to innovate in the field of ophthalmic solutions. His work has been instrumental in advancing medical treatments that improve patient outcomes.
Collaborations
Meyer has collaborated with notable colleagues, including Mina Sooch and Konstantinos Charizanis, contributing to a dynamic research environment that fosters innovation.
Conclusion
Alan R Meyer stands out as a significant figure in the field of ophthalmology, with his innovative patents aimed at improving visual performance and treating ocular disorders. His contributions continue to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile